Abstract:Highlights • Collecting duct NCOR1 deficiency aggravates hypertension induced by Ang II or DOCA-salt. • ENaC mediates the deteriorating effects of collecting duct NCOR1 deficiency in hypertension. • NCOR1 regulates ENaC through MR in collecting duct cells. • Treatment with amiloride ameliorates hypertension in NCOR1 KO mice. • Spironolactone ameliorates the exacerbating effects of collecting duct NCOR1 deficiency on Ang II-induced hypertension. Introduction Nuclear receptor corepressor 1(NCOR1) is reported to play crucial roles in cardiovascular diseases, but its function in the kidney has remained obscure. Objective We aim to elucidate the role of collecting duct NCOR1 in blood pressure (BP) regulation. Methods and Results Collecting duct NCOR1 knockout (KO) mice manifested increased BP and aggravated vascular and renal injury in an angiotensin II (Ang II)-induced hypertensive model. KO mice also showed significantly higher BP than littermate control (LC) mice in deoxycorticosterone acetate (DOCA)-salt model. Further study showed that collecting duct NCOR1 deficiency aggravated volume and sodium retention after saline challenge. Among the sodium transporter in the collecting duct, the expression of the three epithelial sodium channel (ENaC) subunits was markedly increased in the renal medulla of KO mice. Consistently, BP in Ang II-infused KO mice decreased significantly to the similar level as those in LC mice after amiloride treatment. ChIP analysis revealed that NCOR1 deficiency increased the enrichment of mineralocorticoid receptor (MR) on the promoters of the three ENaC genes in primary inner medulla collecting duct (IMCD) cells. Co-IP results showed interaction between NCOR1 and MR, and luciferase reporter results demonstrated that NCOR1 inhibited the transcriptional activity of MR. Knockdown of MR eliminated the increased ENaC expression in primary IMCD cells isolated from KO mice. Finally, BP was significantly decreased in Ang II-infused KO mice after treatment of MR antagonist spironolactone and the difference between LC and KO mice was abolished. Conclusions NCOR1 interacts with MR to control ENaC activity in the collecting duct and to regulate sodium reabsorption and ultimately BP. Targeting NCOR1 might be a promising tactic to interrupt the volume and sodium retention of the collecting duct in hypertension. Graphical abstract Schematic illustration of NCOR1 function in collecting duct cells. Collecting duct NCOR1 is involved in BP regulation by interacting with MR and then down-regulating the expression of ENaC genes. Spironolactone or amiloride treatment ameliorates the exacerbating effects of collecting duct NCOR1 deficiency on hypertension. Download : Download high-res image (92KB) Download : Download full-size image

Rho-associated, coiled-coil-containing protein kinase 2 regulates expression of mineralocorticoid receptor to mediate sodium reabsorption in mice

ULK1 Phosphorylates and Regulates Mineralocorticoid Receptor.

mTOR Regulates Mineralocorticoid Receptor Transcriptional Activity by ULK1-Dependent and -Independent Mechanisms

Single-cell transcriptomics and chromatin accessibility profiling elucidate the kidney-protective mechanism of mineralocorticoid receptor antagonists

Interaction of the Mineralocorticoid Receptor With RACK1 and Its Role in Aldosterone Signaling

Mineralocorticoid Receptor Antagonists Cause Natriuresis in the Absence of Aldosterone

Modulation of transcriptional mineralocorticoid receptor activity by casein kinase 1

OR26-2 mTOR Interacts with the Mineralocorticoid Receptor to Regulate its Activation by Ligand

Mineralocorticoid receptor (MR) antagonist eplerenone and MR modulator balcinrenone prevent renal extracellular matrix remodeling and inflammation via the MR/proteoglycan/TLR4 pathway

Collecting Duct NCOR1 Controls Blood Pressure by Regulating Mineralocorticoid Receptor

Molecular pharmacology of mineralocorticoid receptor antagonists: The role of co-regulators

Abstract 8: Deletion Of The Alpha Subunit Of EnNaC And MTORC2 Inhibition Attenuate DOCA-salt-induced Endothelial Cell And Vascular Stiffness.

Amelioration of albuminuria in ROCK1 knockout mice with streptozotocin-induced diabetic kidney disease.

NF-YC functions as a corepressor of agonist-bound mineralocorticoid receptor

The mineralocorticoid receptor knockout in medaka is further validated by glucocorticoid receptor compensation

Deletion of podocyte Rho-associated, coiled-coil-containing protein kinase 2 protects mice from focal segmental glomerulosclerosis

Renal Function in Mice with Targeted Disruption of the A Isoform of the Na-K-2Cl Co-Transporter

405-P: ROCK2 Activation and Its Role in Folic Acid–Induced Murine Model of Nephropathy

Aldosterone and mineralocorticoid receptors in regulation of the cardiovascular system and pathological remodelling of the heart and arteries

T-Cell Mineralocorticoid Receptor Controls Blood Pressure by Regulating Interferon-Gamma

Lysine-Cysteine-Serine-Tryptophan Inserted into the DNA-Binding Domain of Human Mineralocorticoid Receptor Increases Transcriptional Activation by Aldosterone